Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Spivak

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Psychiatry|July 1, 1997
Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patientsB Spivak, R Mester, J Abesgaus, et al.
The American Journal of Psychiatry|February 1, 1991
Cold agglutinin autoantibodies in psychiatric patients: their relation to diagnosis and pharmacological treatmentB Spivak, M Radwan, J Brandon, et al.
Psychological Medicine|May 1, 1993
Reduced total complement haemolytic activity in schizophrenic patientsB Spivak, M Radwan, J Brandon, et al.
The American Journal of Psychiatry|November 1, 1988
Cold agglutinin titers in psychiatric patientsB Spivak, M Radwan, D Elimelech, et al.
International Journal of Law and Psychiatry|August 26, 1998
The new Israeli psychiatric legislation for the minor (1995) and its relationship to the 1991 Law for the Treatment of the Mentally IllR Mester, T Mozes, R Blumensohn, et al.
Clinical Neuropharmacology|February 22, 2000
Combined electroconvulsive-clozapine therapyM Kupchik, B Spivak, R Mester, et al.
Psychological Medicine|May 25, 2002
Elevated circulatory level of GABA(A)--antagonistic neurosteroids in patients with combat-related post-traumatic stress disorderB Spivak, R Maayan, M Kotler, et al.
Clinical Neuropharmacology|January 12, 2001
Myotoxicity and neurotoxicity during clozapine treatmentI Reznik, L Volchek, R Mester, et al.
Clinical Neuropharmacology|February 1, 1994
Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatmentB Spivak, N Kosower, Y Zipser, et al.
Acta Psychiatrica Scandinavica|May 1, 1999
Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorderB Spivak, Y Vered, R Yoran-Hegesh, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Psychiatry|July 1, 1997
Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patientsB Spivak, R Mester, J Abesgaus, et al.
The American Journal of Psychiatry|February 1, 1991
Cold agglutinin autoantibodies in psychiatric patients: their relation to diagnosis and pharmacological treatmentB Spivak, M Radwan, J Brandon, et al.
Psychological Medicine|May 1, 1993
Reduced total complement haemolytic activity in schizophrenic patientsB Spivak, M Radwan, J Brandon, et al.
The American Journal of Psychiatry|November 1, 1988
Cold agglutinin titers in psychiatric patientsB Spivak, M Radwan, D Elimelech, et al.
International Journal of Law and Psychiatry|August 26, 1998
The new Israeli psychiatric legislation for the minor (1995) and its relationship to the 1991 Law for the Treatment of the Mentally IllR Mester, T Mozes, R Blumensohn, et al.
Clinical Neuropharmacology|February 22, 2000
Combined electroconvulsive-clozapine therapyM Kupchik, B Spivak, R Mester, et al.
Psychological Medicine|May 25, 2002
Elevated circulatory level of GABA(A)--antagonistic neurosteroids in patients with combat-related post-traumatic stress disorderB Spivak, R Maayan, M Kotler, et al.
Clinical Neuropharmacology|January 12, 2001
Myotoxicity and neurotoxicity during clozapine treatmentI Reznik, L Volchek, R Mester, et al.
Clinical Neuropharmacology|February 1, 1994
Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatmentB Spivak, N Kosower, Y Zipser, et al.
Acta Psychiatrica Scandinavica|May 1, 1999
Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorderB Spivak, Y Vered, R Yoran-Hegesh, et al.
Pageof 8